175 related articles for article (PubMed ID: 4056902)
1. Oligodendroglioma: incidence and biological behavior in a defined population.
Mørk SJ; Lindegaard KF; Halvorsen TB; Lehmann EH; Solgaard T; Hatlevoll R; Harvei S; Ganz J
J Neurosurg; 1985 Dec; 63(6):881-9. PubMed ID: 4056902
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and survival-related factors in patients with well-differentiated oligodendrogliomas.
Maiuri F; Del Basso De Caro ML; Iaconetta G; Peca C; Esposito M; de Divitiis E
Zentralbl Neurochir; 2006 Nov; 67(4):204-9. PubMed ID: 17106834
[TBL] [Abstract][Full Text] [Related]
3. Oligodendrogliomas in children.
Dohrmann GJ; Farwell JR; Flannery JT
Surg Neurol; 1978 Jul; 10(1):21-5. PubMed ID: 684601
[TBL] [Abstract][Full Text] [Related]
4. Outcomes and Prognostic Factors in Pediatric Oligodendroglioma: A Population-Based Study.
Goel NJ; Abdullah KG; Lang SS
Pediatr Neurosurg; 2018; 53(1):24-35. PubMed ID: 29131101
[TBL] [Abstract][Full Text] [Related]
5. Oligodendroglioma: does deferring treatment compromise outcome?
Feigenberg SJ; Amdur RJ; Morris CG; Mendenhall WM; Marcus RB; Friedman WA
Am J Clin Oncol; 2003 Jun; 26(3):e60-6. PubMed ID: 12796617
[TBL] [Abstract][Full Text] [Related]
6. Extent of resection and survival for oligodendroglioma: a U.S. population-based study.
Kinslow CJ; Garton ALA; Rae AI; Marcus LP; Adams CM; McKhann GM; Sisti MB; Connolly ES; Bruce JN; Neugut AI; Sonabend AM; Canoll P; Cheng SK; Wang TJC
J Neurooncol; 2019 Sep; 144(3):591-601. PubMed ID: 31407129
[TBL] [Abstract][Full Text] [Related]
7. Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survival.
Puduvalli VK; Hashmi M; McAllister LD; Levin VA; Hess KR; Prados M; Jaeckle KA; Yung WK; Buys SS; Bruner JM; Townsend JJ; Davis R; Sawaya R; Kyritsis AP
Oncology; 2003; 65(3):259-66. PubMed ID: 14657600
[TBL] [Abstract][Full Text] [Related]
8. Intracranial oligodendrogliomas: imaging findings in 35 untreated cases.
Lee YY; Van Tassel P
AJR Am J Roentgenol; 1989 Feb; 152(2):361-9. PubMed ID: 2783515
[TBL] [Abstract][Full Text] [Related]
9. Oligodendroglioma: an analysis of prognostic factors and treatment results.
Allam A; Radwi A; El Weshi A; Hassounah M
Am J Clin Oncol; 2000 Apr; 23(2):170-5. PubMed ID: 10776979
[TBL] [Abstract][Full Text] [Related]
10. Cerebral oligodendrogliomas in children: an analysis of 15 cases.
Rizk T; Mottolèse C; Bouffet E; Jouvet A; Guyotat J; Bret P; Lapras C
Childs Nerv Syst; 1996 Sep; 12(9):527-9. PubMed ID: 8906367
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging volumetric assessment of the extent of contrast enhancement and resection in oligodendroglial tumors.
Sankar T; Moore NZ; Johnson J; Ashby LS; Scheck AC; Shapiro WR; Smith KA; Spetzler RF; Preul MC
J Neurosurg; 2012 Jun; 116(6):1172-81. PubMed ID: 22424566
[TBL] [Abstract][Full Text] [Related]
12. From the archives of the AFIP: Oligodendroglioma and its variants: radiologic-pathologic correlation.
Koeller KK; Rushing EJ
Radiographics; 2005; 25(6):1669-88. PubMed ID: 16284142
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic study of forty-four histologically pure supratentorial oligodendrogliomas.
Prayson RA; Mohan DS; Song P; Suh JH
Ann Diagn Pathol; 2000 Aug; 4(4):218-27. PubMed ID: 10982299
[TBL] [Abstract][Full Text] [Related]
14. Factors possibly influencing the prognosis of oligodendroglioma.
Sun ZM; Genka S; Shitara N; Akanuma A; Takakura K
Neurosurgery; 1988 May; 22(5):886-91. PubMed ID: 3380278
[TBL] [Abstract][Full Text] [Related]
15. Statistical analysis of clinicopathological features, radiotherapy, and survival in 170 cases of oligodendroglioma.
Lindegaard KF; Mørk SJ; Eide GE; Halvorsen TB; Hatlevoll R; Solgaard T; Dahl O; Ganz J
J Neurosurg; 1987 Aug; 67(2):224-30. PubMed ID: 3598683
[TBL] [Abstract][Full Text] [Related]
16. [Advances in diagnosis and treatment of oligodendrogliomas of the brain. Eighty-four surgical patients (author's transl)].
Paillas JE; Grisoli F; Hassoun J; Torres-Garcia T; De Laforte C
Sem Hop; 1982 Apr; 58(14):851-6. PubMed ID: 6281897
[TBL] [Abstract][Full Text] [Related]
17. Chromosome 1p/19q status combined with expression of p53 protein improves the diagnostic and prognostic evaluation of oligodendrogliomas.
Xiong J; Liu Y; Wang Y; Ke RH; Mao Y; Ye ZR
Chin Med J (Engl); 2010 Dec; 123(24):3566-73. PubMed ID: 22166632
[TBL] [Abstract][Full Text] [Related]
18. [Various features of the morphology, clinical picture and treatment of oligodendrogliomas of the cerebral hemispheres].
Romodanov AP; Malikov AI
Zh Vopr Neirokhir Im N N Burdenko; 1980; (5):23-7. PubMed ID: 7435065
[TBL] [Abstract][Full Text] [Related]
19. Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis.
Ino Y; Betensky RA; Zlatescu MC; Sasaki H; Macdonald DR; Stemmer-Rachamimov AO; Ramsay DA; Cairncross JG; Louis DN
Clin Cancer Res; 2001 Apr; 7(4):839-45. PubMed ID: 11309331
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in oligodendrogliomas.
Westergaard L; Gjerris F; Klinken L
Acta Neurochir (Wien); 1997; 139(7):600-5. PubMed ID: 9265951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
